Volume 9 Supplement 1
Proceedings of 18th Pediatric Rheumatology European Society (PReS) Congress
Meeting abstracts
Edited by Rolando Cimaz, Pavla Dolezalova, Marco Gattorno, Hermann Girschick, Michael Hofer, Sue Maillard, Alberto Martini, Pierre Quartier, Carlos Rose, Johannes Roth, Rebecca ten Cate and Carine Wouters.
18th Pediatric Rheumatology European Society (PReS) Congress. Go to conference site.
Bruges, Belgium14-18 September 2011
Page 5 of 8
-
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P158
-
Longitudinal evaluation of bone mass in adolescents and young adults with juvenile idiopathic arthritis: the role of bone mass determinants in a large cohort of patients
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P159 -
Does childhood health assessment questionnaire can predict outcome of patients with juvenile idiopathic arthritis?
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P160 -
Relationship of serum ghrelin, leptin, resistin, adiponectin levels with nutritional status and inflammatory determinants in juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P161 -
Switching to an alternative biological agent in juvenile idiopathic arthritis (I)
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P162 -
Switching to an alternative biological agent in juvenile idiopathic arthritis (II)
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P163 -
Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): tender 52-week data
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P164 -
Dynamics of longitudinal growth in children with idiopathic rheumatoid arthritis in response to infliximab treatment
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P165 -
Epigenetic modulation with oral histone deacetylase (HDAC) inhibitor as a new treatment option in JIA
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P166 -
Early onset chronic arthritis associated with chromosome deletion 22 q11.2 syndrome. Is it juvenile idiophatic arthritis?
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P167 -
Coeliac disease and intestinal inflammation in juvenil idiopathic arthritis
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P168 -
Etanercept improves pro-atherosclerotic biomarkers in children with juvenile idiopatic arthritis
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P169 -
Preliminary data on insulin sensitivity in non-obese prepubertal children affected by juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P170 -
DNase I levels and disease outcome in JIA patients treated with etanercept
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P171 -
Mandibular ramus length and condylar changes in Juvenile Idiopathic Arthritis
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P172 -
Juvenile idiopathic arthritis with dry synovitis: clinical and imaging aspects in a cohort of 6 patients
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P173 -
Temporomandibular joint involvement (TMJ), a silent disease with severe alterations in young adulthood patients affected by juvenile idiophatic arthritis (JIA)
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P174 -
Juvenile idiopathic arthritis and Wegener granulomatosis: causal or casual relationship?
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P175 -
One-year observation of leflunomide effectiveness and saftey in juvenile idiopathic arthritis : a clinical practice review (preliminary data)
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P176 -
Mandibular distraction osteogenesis in patients with unilateral TMJ involvement in juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P177 -
Systemic onset Juvenile Idiopathic Arthritis (SoJIA): a monocentric study of 114 patients
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P178 -
Soluble Receptor for Advanced Glycation End Products (sRAGE) is decreased in patients with Juvenile Idiopathic Arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P179 -
Efficacy of adalimumab in refractory juvenile idiopathic arthritis related uveitis: report of 6 cases
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P180 -
German evidence and consensus based guidelines 2010 for the treatment of juvenile idiopathic arthritis (JIA)
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P181 -
An Altered Peptide Ligand derived from heat-shock protein 60 induces regulatory T cells in JIA patients and suppresses adjuvant-induced arthritis
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P182 -
Autologous stem cell transplantation in autoimmune arthritis restores immune homeostasis by renewal of the natural Treg compartment
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P183 -
Parental preferences for treatment: Preliminary report from a randomised comparison of treatment strategies in (early) juvenile idiopathic arthritis (BeSt for Kids trial)
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P184 -
MyastheniaGravis(MG) in a patient with Juvenile Idiopathic Arthritis
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P185 -
Tocilizumab in JIA patients who have inadequate response to anti-tumour necrosis factor therapy
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P186 -
Experience of the concentration of methotrexate evaluation in children with juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P187 -
Use of bone marrow cells (BMCS) added to Platelet-Rich Plasma (PRP) for treatment of bone degenerative processes in JIA patients: a case report
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P188 -
Abatacept for severe anti-TNF-alfa refractory JIA-associated uveitis: one year follow-up
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P189 -
Anakinra for systemic onset juvenile idiopathic arthritis: experience as a second versus first line treatment
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P190 -
Long term follow-up after sudden withdrawal from a multicentric study of abatacept in juvenile idiopathic arthritis – data from the Portuguese cohort
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P191 -
A meta-analysis to estimate the “real” placebo effect in juvenile idiopathic arthritis (JIA) trials
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P192 -
JIA affected sibling pairs present high correlation for ANA and ILAR category
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P193 -
The PRINTO provisional definition of remission in juvenile dermatomyositis
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P194 -
Juvenile idiopathic arthritis (JIA): can an integrated medicine be possible?
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P195 -
A new approach to defining inactive disease, minimal disease activity and parent- and child-acceptable symptom state in juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P196 -
Agreement between objective and subjective definitions of inactive disease, remission and minimal disease activity in juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P197 -
Assessment of active TGFβ with a bioassay
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P198 -
Auto-antibody testing for children on biologic therapies for rheumatological conditions: results of audit
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P199 -
Intra-articular corticosteroid therapy in oligoarticular juvenile arthritis: our clinical experience
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P200 -
Phase III, multi-centre, randomised, double blind, Placebo-controlled study for treatment of juvenile ankylosing spondylitis (AS) with Adalimumab
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P201 -
Safety and efficacy of tocilizumab treatment in children with systemic onset of juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P202 -
Adverse events of methotrexate treatment in JIA
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P203 -
The use of tocilizumab in a child with systemic onset juvenile idiopathic arthritis and ganglioneuroblastoma
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P204 -
An alternative analgesic agent for intra-articular corticosteroid injections (IAI) in juvenile idiopathic arthritis (JIA) – a fentanyl lollipop
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P205 -
Correlation between clinical indices and findings of joint ultrasonography in juvenile idiopathic arthritis with adalimumab therapy
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P206 -
Inactive disease and remission rates after intraarticular steroids as initial therapy for juvenile idiopathic arhtritis (JIA)
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P207
Official journal of
Annual Journal Metrics
-
Citation Impact
3.413 - 2-year Impact Factor (2021)
3.970 - 5-year Impact Factor (2021)
1.315 - Source Normalized Impact per Paper (SNIP)
1.051 - SCImago Journal Rank (SJR)Speed
43 days to first decision for all manuscripts (Median)
53 days to first decision for reviewed manuscripts only (Median)
Usage
917,107 Downloads (2021)
661 Altmetric mentions (2021)